Cravath, Swaine & Moore LLP Logo
  • Practices
  • People
  • Careers
  • News & Insights
  • Practices
  • People
  • Careers
  • News & Insights
  • Our Story
  • The Cravath System
  • Diversity & Inclusion
  • Pro Bono
  • Alumni Journal
  • 200.Cravath

Cravath’s London Office Moves to 100 Cheapside

Read More

News & Insights

Dave Kappos Participates in the Economist Impact’s Powering the Innovation Economy With 5G Event

December 15, 2021

On December 9, 2021, Cravath partner David J. Kappos participated in “Powering the Innovation Economy With 5G,” an event held virtually by Economist Impact. Dave’s panel, entitled “Enabling Invention and Innovation,” discussed the uses of 5G, opportunities and challenges within the global innovation economy, and how businesses and regulators can support the next generation of inventors.

Related Practices & Industries

  • Corporate
  • Intellectual Property
  • Technology
  • Telecommunications

Speakers

Photo
Name
David J. Kappos
Title
Corporate
Title
Partner
Email
dkappos@cravath.com
Phone
+1-212-474-1168
vCard
Download vCard

    Education

    • J.D., 1990, University of California, Berkeley, School of Law
    • B.S., 1983, University of California, Davis
      summa cum laude

    Admitted In

    • New York
    • California
    • District of Columbia

    Related News & Insights

    Deals & Cases

    November 29, 2021

    Elsevier’s Acquisition of Osmosis

    On November 29, 2021, Elsevier, a global leader in research publishing and information analytics and part of RELX, announced that it has acquired Osmosis, a U.S.‑based visual learning education platform for millions of current and future healthcare professionals and their patients. RELX is a global provider of information‑based analytics and decision tools for professional and business customers. Cravath is representing RELX in connection with the transaction.

    Deals & Cases

    November 29, 2021

    Vaxxinity, Inc.’s Initial Public Offering

    Cravath represented Vaxxinity, Inc. in connection with its initial public offering. Vaxxinity is a U.S.‑based global biotechnology company pioneering a new class of immunotherapeutic vaccines to democratize health. Shares began trading on November 11, 2021 on The Nasdaq Global Market.

    Deals & Cases

    November 15, 2021

    CyrusOne’s $15 Billion Acquisition by KKR and Global Infrastructure Partners

    On November 15, 2021, CyrusOne Inc. (“CyrusOne”), a premier global data center REIT, KKR, a leading investment firm, and Global Infrastructure Partners, a leading infrastructure investor, announced a definitive agreement pursuant to which KKR and GIP will acquire all outstanding shares of common stock of CyrusOne for $90.50 per share in an all‑cash transaction valued at approximately $15 billion, including the assumption of debt. Upon completion of the transaction, CyrusOne will be a privately held company wholly owned by KKR and GIP and CyrusOne’s common stock will no longer be listed on any public market. Cravath is representing CyrusOne in connection with the transaction.

    Deals & Cases

    November 15, 2021

    Eurazeo’s Acquisition of Scaled Agile

    On November 15, 2021, Eurazeo, a leading global investment group with considerable private equity, real estate and private debt expertise, announced the signature of an agreement for the acquisition of Scaled Agile, a leading provider of the framework, platform, professional training content and certifications for implementing business agility practices across the enterprise. Eurazeo and its partners will hold a majority stake and invest approximately $300 million. Cravath is representing Eurazeo in connection with the transaction.

    Cravath Bicentennial

    Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

    Explore

    Cravath, Swaine & Moore LLP Logo
    • CONTACT US
    • OUR STORY
    • ALUMNI PORTAL
    • DISCLAIMERS & NOTICES

    Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.